Which hedge funds own ALLO? ALLOGENE THERAPEUTICS INC, Q2 2026 13F holders
30 tracked hedge funds disclosed a position in ALLO (ALLOGENE THERAPEUTICS INC) in their Q2 2026 13F filings, worth $220.4m in total. The largest holder by portfolio weight is GordonMD Global Investments LP at 5.3% of its book. 6 opened a new position this quarter: Sio Capital Management, LLC, Ghisallo Capital Management LLC, Rangeley Capital, LLC, RTW Investments, LP. 9 exited: MPM Bioimpact LLC, Scientech Research LLC, DeepCurrents Investment Group LLC.
- 30
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 6
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 9
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $47.7m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $9.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $220m
- Combined value Sum of the holders' reported positions in the security.
- 2.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| MPM Bioimpact LLC | 0.4% | $5.5m |
| Scientech Research LLC | 0.09% | $113k |
| DeepCurrents Investment Group LLC | 0.01% | $156k |
| Balyasny Asset Management L.P. | 0.01% | $2.9m |
| Cygnus Capital Advisors, LLC | 0.01% | $8.0k |
| ExodusPoint Capital Management, LP | 0.0% | $157k |
| Tudor Investment Corp ET AL | 0.0% | $176k |
| Point72 Asset Management, L.P. | 0.0% | $540k |
| Hudson Bay Capital Management LP | 0.0% | $35.9k |
Ownership over time
Who discovered ALLO first? Beta
| Avoro Capital Advisors LLC | Q4 2018 | +0.7 pts |
| Perceptive Advisors LLC | Q4 2018 | +0.5 pts |
| Tri Locum Partners LP | Q2 2022 | −0.1 pts |
| Casdin Capital, LLC | Q1 2020 | −0.1 pts |
| Sessa Capital IM, L.P. | Q2 2021 | −0.5 pts |
| Woodline Partners LP | Q2 2022 | −0.9 pts |
| EcoR1 Capital, LLC | Q2 2022 | −1.1 pts |
| Wildcat Capital Management, LLC high conviction | Q1 2020 | −5.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.